Menstrual Disorders in Adolescent Females: Current Concepts

Disease-a-Month

Volumn 55, Issue 2, 2009, Pages 45-113

  Greydanus, Donald E ^a   Omar, Hatim A ^a   Tsitsika, Artemis K ^a   Patel, Dilip R ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINOCAPROIC ACID; ANGELICA SINENSIS EXTRACT; ANTICOAGULANT AGENT; ANTIFIBRINOLYTIC AGENT; ANTINEOPLASTIC AGENT; ANTITHROMBOCYTIC AGENT; BUSERELIN; CONTRACEPTIVE AGENT; CYCLOSPORIN; DANAZOL; DESMOPRESSIN; ESTROGEN; FERROUS SULFATE; LEUPRORELIN; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; MINOXIDIL; NAFARELIN ACETATE; NONSTEROID ANTIINFLAMMATORY AGENT; NORETHISTERONE ACETATE; ORAL CONTRACEPTIVE AGENT; PENICILLAMINE; PHENOTHIAZINE; PHENYTOIN; PRASTERONE; PROGESTERONE; ROSIGLITAZONE; SPIRONOLACTONE; STREPTOMYCIN; TRANEXAMIC ACID; UNINDEXED DRUG;

ABDOMINAL PAIN; ACNE; ADOLESCENT; AMENORRHEA; ANEMIA; BLOATING; BLOOD CLOTTING DISORDER; BREAKTHROUGH BLEEDING; COLITIS; CONSTIPATION; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DYSMENORRHEA; ECTOPIC PREGNANCY; ENDOMETRIOSIS; FEMALE; FLUSHING; FOLLICULAR PHASE; GASTROINTESTINAL SYMPTOM; GONADAL DISEASE; HEADACHE; HEMOPHILIA; HIRSUTISM; HUMAN; HYPERPHAGIA; HYPERTRICHOSIS; HYPONATREMIA; INTRAUTERINE CONTRACEPTIVE DEVICE; LUTEAL PHASE; MENSTRUATION; MENSTRUATION DISORDER; METRORRHAGIA; NAUSEA; OVARY INSUFFICIENCY; OVARY POLYCYSTIC DISEASE; OVARY TUMOR; OVULATION; PELVIC INFLAMMATORY DISEASE; PREMENSTRUAL SYNDROME; REVIEW; SECONDARY AMENORRHEA; SIDE EFFECT; THROMBOSIS; ULCER; VOMITING; VON WILLEBRAND DISEASE; WEAKNESS; WEIGHT GAIN;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BLOOD COAGULATION DISORDERS; DEAMINO ARGININE VASOPRESSIN; FEMALE; HEMOSTATICS; HUMANS; MENSTRUAL CYCLE; MENSTRUATION DISTURBANCES;

EID: 58149517194     PISSN: 00115029     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.disamonth.2008.10.004     Document Type: Review

References (155)

1. Greydanus D.E. Breast and gynecologic disorders. In: Hofmann A.D., and Greydanus D.E. (Eds). Adolescent Medicine. 3rd ed. (1997), Appleton & Lange, Stamford, CT 520-565 Ch. 25
2. Greydanus D.E., Omar H., Tsitsika A., et al. Menstrual disorders in adolescents. In: Omar H., Greydanus D.E., and Tsitsika A. (Eds). Pediatric and Adolescent Sexuality and Gynecology (2009), Novi Science Publishers, Merrick. NY 175-260 Ch. 8
3. Draznin M.D. Endocrinology. In: Greydanus D.E., Patel D.R., and Pratt H.D. (Eds). Essential Adolescent Medicine (2006), McGraw-Hill Medical Publishers, NY 234-250 Ch 13
4. Kaplowitz P.B. Puberty, normal, and menarche. In: Hillard P.J.A. (Ed). The 5-Minute Obstetrics and Gynecology Consult (2008), Wolters Kluwer/Lippincott Williams & Wilkins, Philadelphia, PA 8-39
5. Kaplowitz P.B. Pubertal development in girls: secular trends. Curr Opin Obstet Gynecol 18 (2006) 487-491
6. Greenfield T.P., and Blythe M.J. Menstrual disorders in adolescents. In: Greydanus D.E., Patel D.R., and Pratt H.D. (Eds). Essential Adolescent Medicine (2006), McGraw-Hill Medical Publishers, New York, NY 591-612 Ch. 28
7. Strickland J.L., and Wall J.W. Abnormal uterine bleeding in adolescents. Obstet Gynecol Clin North Am 30 (2003) 321-335
8. Knobil E. The neuroendocrine control of the menstrual cycle. Recent Prog Horm Res 36 (1980) 53-58
9. Greydanus D.E., Tsitsika A., and Gains M. The gynecology system and the adolescent. In: Greydanus D.E., Feinberg A.N., Patel D.R., et al. (Eds). The Pediatric Diagnostic Examination (2007), McGraw-Hill Medical Publishers, New York, NY 701-749 Ch. 22
10. Hillier S.G., Eichert E., and VanHall E.V. Control of preovulatory follicular estrogen biosynthesis in the human ovary. J Clin Endocrinol Metab 52 5 (1981) 847-856
11. Lockwood G.M., Muttukrishna S., and Ledger W.L. Inhibins and activins in human ovulation, conception and pregnancy. Hum Rep Update 4 3 (1998) 284-295
12. Filicori M., Santoro N., and Merriam G. Characterization of the physiological pattern of episodic gonadotropin secretion throughout the human menstrual cycle. J Clin Endocrinol Metab 62 6 (1986) 1136
13. Tibibzadeh S., and Satyaswaroop P.G. Sex steroid receptors in lymphoid cells of human endometrium. Am J Clin Pathol 91 (1998) 656-663
14. Salamonsen L.A., and Woolley D.E. Menstruation: induction by matrix metalloproteinases and inflammatory cells. J Reprod Immunol 44 (1999) 1-27
15. Salamonsen L.A., Butt A.R., and Hammond F.R. Induction of endometrial matrix metalloproteinases, but not their tissue inhibitors, is modulated by progesterone withdrawal in an in vitro model for menstruation. J. Clin Endocrinol Metab 82 (1997) 1409-1415
16. Hampton A.L., and Salmonsen L.A. Expression of messenger ribonucleic acid encoding matrix metalloproteinases and their tissue inhibitors is related to menstruation (1994) R1-R3 141
17. Finn C.A. Implantation, menstruation and inflammation. Biol Rev 61 (1986) 313-328
18. Sharkey A., Day K., McPherson A., et al. Vascular endothelial growth factor expression in human endometrium is regulated by hypoxia. J Clin Endocrinol Metab 85 (2000) 402-409
19. Smith S.K. Angiogenesis, vascular endothelial growth factor and the endometrium. Hum Reprod Update 4 (1998) 509-519
20. Weston G., and Rogers P.A.W. Endometrial angiogenesis. Bailliere's Clin Obstet Gynaecol 14 (2000) 919-936
21. Mueller M.D., Lebovic D.I., Garrett E., et al. Neutrophils infiltrating the endometrium express vascular endothelial growth factor: potential role in endometrial angiogenesis. Fertil Steril 74 (2000) 107-112
22. Bukulmez O. Luteal phase defect: myth or reality. Obstet Gynecol Clin North Am 31 (2004) 727-744
23. Scheib S.A., and Batzer F. Luteal phase defect. In: Hillard P.J.A. (Ed). The 5-Minute Obstetrics and Gynecology Consult (2008), Wolters Kluwer/Lippincott Williams & Wilkins, Philadelphia, PA 124-125
24. Hillard P.J. Adolescent and pediatric gynecology: an introduction. Curr Opin Obstet Gynecol 18 (2006) 485-486
25. Deitch H.R., and Hillard P.J. Menstrual disorders in the college age female. Pediatr Clin North Am 52 (2005) 101-125
26. Pinto S.M. Prepubertal menarche: a defined clinical entity. Am J Obstet Gynecol 195 (2006) 327-329
27. Sugar N.F. Common gynecologic problems in prepubertal girls. Pediatr Rev 27 (2006) 213-223
28. Friberg B., Orno A.K., Lindgren A., et al. Bleeding disorders among young women: a population-based prevalence study. Acta Obstet Gynecol Scand 85 2 (2006) 200-206
29. Chuong C.J., and Renner P.F. Management of abnormal uterine bleeding. Am J Obstet Gynecol 175 3 (1996) 787-792
30. Hillard P.J.A. Menstruation on young girls: a clinical perspective. Obstet Gynecol 99 4 (2002) 655-662
31. Fraser I.S., Hickey M., and Song J.Y. A comparison of mechanisms underlying disturbances of bleeding caused by spontaneous dysfunctional uterine bleeding or hormonal contraception. Hum Reprod 11 2 (1996) 165-178
32. Chwalisz K., and Garfield R.E. Role of nitric oxide in implantation and menstruation. Hum Reprod 15 3 (2000) 96-111
33. Wall J.W., and Strickland J.L. Bleeding, abnormal uterine, in adolescents. In: Hillard P.J.A. (Ed). The 5-Minute Obstetrics and Gynecology Consult (2008), Wolters Kluwer/Lippincott Williams & Wilkins, Philadelphia, PA 4-5
34. Lukes A. Disorders of hemostasis and escessive menstrual bleeding: prevalence and clinical impact. Fertil Steril 84 (2005) 1345-1351
35. Hord J.D. Anemia and coagulation disorders in adolescents. Adolesc Med 10 3 (1999) 359-367
36. Kulkarni R., Gera R., and Scott-Emuakpor A.B. Adolescent hematology. In: Greydanus D.E., Patel D.R., Pratt H.D., et al. (Eds). Essential Adolescent Medicine (2006), McGraw-Hill Medical Publishers, New York, NY 111-145 Ch. 17
37. Bennett K., Daley M.L., and Pike C. Factor V deficiency and menstruation: a gynecologic challenge. Obstet Gynecol 89 5 Pt. 2 (1997) 839-840
38. Munro M.G., and Cunningham E.S. Bleeding, abnormal uterine: heavy menstrual bleeding. In: Hillard P.J.A. (Ed). The 5-Minute Obstetrics and Gynecology Consult (2008), Wolters Kluwer/Lippincott Williams & Wilkins, Philadelphia, PA 6-7
39. Koudes P.A., Phatak P.D., Burkart P., et al. Gynaecological and obstetrical morbidity in women with type I von Willebrand disease: results of a patient survey. Haemophilia 6 2 (2000) 54-60
40. Koudes P. Hemostasis and menstruation: appropriate investigation for underlying hemostasis in women with excessive menstrual bleeding. Fertil Steril 84 (2005) 1338-1344
41. Claessens E.A., and Cowell C.A. Acute adolescent menorrhagia. Am J Obstet Gynecol 139 (1981) 277-282
42. Kadir R.A., Sabin C.A., Pollard D., et al. Quality of life during menstruation in patients with inherited bleeding disorders. Haemophilia 4 6 (1998) 836-841
43. Falcone T., Desjardins C., Bourque J., et al. Dysfunctional uterine bleeding in the adolescent. Reprod Med 39 (1994) 761-764
44. Kirtava A., Drews C., Lally C., et al. Medical, reproductive and psychosocial experiences of women diagnosed with von Willebrand's disease receiving care in haemophilia treatment centres: a case-control study. Hemophilia 9 3 (2003) 292-297
45. Kadir R.A., Economides D.L., Sabin C.A., et al. Assessment of menstrual blood loss and gynaecological problems in patients with inherited bleeding disorders. Haemophilia 5 1 (1999) 40-48
46. Kadir R.A., Sabin C.A., Pollard D., et al. Quality of life during menstruation in patients with inherited bleeding disorders. Haemophilia 4 6 (1998) 836-841
47. Quint E.H., and Smith Y.R. Abnormal uterine bleeding in adolescents. J Midwifery Womens Health 48 3 (2003) 186-191
48. Collett T.F. Irregular uterine bleeding in adolescents. J Pediatr Health Care 16 6 (2002) 313 321-2
49. Livingstone M., and Fraser J.S. Mechanism of abnormal uterine bleeding. Hum Reprod Update 8 1 (2002) 60-67
50. Lavin C. Dysfunctional uterine bleeding in adolescents. Curr Opin Pediatr 8 4 (1996) 328-332
51. Southam A.L., and Richart R.M. The prognosis for adolescents with menstrual abnormalities. Am J Obstet Gynecol 94 5 (1966) 637-645
52. Greydanus D.E., Rimsza M.E., and Matytsina L. Contraception for college students. Pediatr Clin No Amer 52 (2005) 135-161
53. Hickey M. Progestogens versus oestrogens and progestogens for irregular bleeding associated with anovulation. Cochrane Database Sys Rev 1 (2007) (CD002126)
54. Cunningham S., and Munro M.B. Bleeding, abnormal uterine: irregular and intermenstrual. In: Hillard P.J.A. (Ed). The 5-Minute Obstetrics and Gynecology Consult (2008), Wolters Kluwer/Lippincott Williams & Wilkins, Philadelphia, PA 10-11
55. Apgar B.S., Kaufman D., Uche G.N., et al. Treatment of menorrhagia. Am Fam Phys 75 (2007) 1813-1819
56. Greydanus D.E. Contraception in chronically ill adolescents. Internation J Disabil Hum Develop 2007 (2009) 1
57. Best K.A., and Kaunitz A.M. Bleeding, abnormal uterine: with hormonal therapy or contraception. In: Hillard P.J.A. (Ed). The 5-Minute Obstetrics and Gynecology Consult (2008), Wolters Kluwer/Lippincott Williams & Wilkins, Philadelphia, PA 8-9
58. Bevan J.A., Maloney K.W., Hillery C.A., et al. Bleeding disorders: a common cause of menorrhagia in adolescents. J Pediatr 138 6 (2001) 856-861
59. Greydanus D.E., Paul K., and Patel D.R. Menstrual bleeding and the adolescent. Italian J Adol Med (2008)
60. Matytsina L.A., Zoloto E.V., Sinenko L.V., et al. Dysfunctional uterine bleeding in adolescents: concepts of pathophysiology and management. Prim Care: Clin Office Pract 33 2 (2006) 503-515
61. Rizk D.E., and Kumar R.M. Congenital afibrinogenemia: treatment of excessive menstrual bleeding with continuous oral contraceptive. Am J Hematol 52 3 (1996) 237-238
62. Greydanus D.E., Tsitsika A., and Matytsina L. Contraception. In: Omar H., Greydanus D.E., and Tsitsika A. (Eds). Pediatric and Adolescent Sexuality and Gynecology (2009), Novi Science Publishers, Merrick, NY 300-350 Ch. 9
63. A progestin-releasing IUD for long-term contraception. Med Lett 67 (2001) 7-8
64. Phillips V., Graham C.T., Manek S., et al. The effects of levonorgestrel intrauterine system (Mirena coil) on endometrial morphology. J Clin Pathol 56 (2003) 305-307
65. Majorbanks J. Surgery versus medical therapy for heavy menstrual bleeding. Cochrane Database Sys Rev 2 (2006) (CD005326)
66. Iglesias E.A., and Coupey S.M. Menstrual cycle abnormalities: diagnosis and management. State of the Art Reviews. Adolesc Med 10 2 (1999) 255-273
67. Joffe A., and Blythe M.J. Handbook of adolescent medicine. Adolesc Med 14 (2003) 289-307
68. Polaneczky M.M., and Slap G.B. Menstrual disorders in the adolescent: amenorrhea. Pediatr Rev 13 (1992) 43-46
69. The Practice Committee of the American Society for Reproductive Medicine. Current evaluation of amenorrhea. Fertil Steril 86 suppl 4 (2006) S148-S155
70. Welt C.K. Etiology, diagnosis, and treatment of primary amenorrhea. UptoDate Online 14 (2005) 3
71. Sybert V.P. Turner syndrome. N Engl J Med 351 (2004) 1227-1238
72. Posner J.C. Early detection of imperforate hymen prevents morbidity from delays in diagnosis. Pediatrics 115 (2005) 1008-1012
73. Liang C.C. Long-term follow-up of women who underwent surgical correction of imperforate hymen. Arch Obstet Gynecol 269 (2003) 5-8
74. Welt C.K. Etiology, diagnosis, and treatment of secondary amenorrhea. UptoDate Online 14 (2005) 3
75. Mitan L.A.P. Diet, eating disorder: anorexia nervosa. In: Hillard P.J.A. (Ed). The 5-Minute Obstetrics and Gynecology Consult (2008), Wolters Kluwer/Lippincott Williams & Wilkins, Philadelphia, PA 268-269
76. Reddy V. Eating disorders. In: Omar H., Greydanus D.E., and Tsitsika A. (Eds). Pediatric and Adolescent Sexuality and Gynecology (2009), Novi Science Publishers, Merrick, NY 340-361 Ch. 15
77. Mitan L.A.P. Menstrual dysfunction in anorexia nervova. J Pediatr Adolesc Gynecol 17 (2004) 81-85
78. Pratt H.D., and Tsitsika A.K. Fetal, childhood, and adolescence interventions leading to adult disease prevention. Primary Care Clin Office Pract 34 (2007) 203-217
79. Witchel S.F. Hyperandrogenism in adolescents. Adolesc Med 13 (2002) 89-99
80. Bondy C.A. Turner Syndrome Study Group: care of girls and women with Turner Syndrome: a guideline of the Turner Syndrome Study Group. J Clin Endocrinol Metab 92 (2007) 10-25
81. Lee P.A., and Houk C.P. Gonadal dysgenesis. In: Hillard P.J.A. (Ed). The 5-Minute Obstetrics and Gynecology Consult (2008), Wolters Kluwer/Lippincott Williams & Wilkins, Philadelphia, PA 112-113
82. Backeljauw P.F. Turner syndrome. In: Hillard P.J.A. (Ed). The 5-Minute Obstetrics and Gynecology Consult (2008), Wolters Kluwer/Lippincott Williams & Wilkins, Philadelphia, PA 186-187
83. Salmi D.J., Zisser H.C., and Jovanovic L. Screening for and treatment of polycystic ovary syndrome in teenagers. Exp Biol Med 229 (2004) 369-377
84. Azziz R. PCOS: a diagnostic challenge. Reprod Biomed Online 8 (2004) 644-648
85. Orio F., Vuolo L., Palomba S., et al. Metabolic and cardiovascular consequences of polycystic ovary syndrome. Minerva Ginecol 60 (2008) 39-51
86. Miller R.J. Bleeding, abnormal uterine: oligomenorrhea. In: Hillard P.J.A. (Ed). The 5-Minute Obstetrics and Gynecology Consult (2008), Williams & Wilkins, Kluwer/Lippincott 12-13
87. Paradise J. Evaluation of oligomenorrhea in adolescence. UptoDate Online 14 (2006) 3-6
88. Legro R.S., Castracane V.D., and Kauffman R.P. Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls. Obstet Gynecol Surv 59 (2004) 141-154
89. Ferriman D. Clinical assessment of body hair growth in women. J Clin Endocrinol 21 (1961) 1440-1447
90. Wild R.A. Ferriman Gallwey self-scoring: performance assessment in women with polycystic ovary syndrome. J Clin Endocrinol Metabol 90 (2005) 4112-4114
91. Rager K.M. Acanthosis nigricans. In: Hillard P.J.A. (Ed). The 5-Minute Obstetrics and Gynecology Consult (2008), Wolters Kluwer/Lippincott Williams & Wilkins, Philadelphia, PA 62-63
92. The Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19 (2004) 41-47
93. Azziz R. Diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature. J Clin Endocrinol Metabol 91 3 (2006) 781-785
94. Omar H.A. Clinical profiles, occurrence, and management of adolescent patients with HAIR-AN syndrome. Sci World J 4 (2004) 507-511
95. Aubuchon M. Polycystic ovarian syndrome (PCOS). In: Hillard P.J.A. (Ed). The 5-Minute Obstetrics and Gynecology Consult (2008), Wolters Kluwer/Lippincott Williams & Wilkins, Philadelphia, PA 158-159
96. Ehrmann D.A. Polycystic ovary syndrome. N Engl J Med 352 (2005) 1223-1236
97. Guzick D.S. Polycystic ovary syndrome. Obstet Gynecol 103 (2004) 181-193
98. Orchard T.J. The effect of metformin and intensive lifestyle intervention in the metabolic syndrome. The Diabetes Prevention Program randomized trial. Ann Intern Med 142 (2005) 611-619
99. Mastorakos G. Polycystic ovary syndrome in adolescents: current and future treatment options. Paediatr Drugs 8 (2006) 311-318
100. Bricker L., and Greydanus D.E. The metabolic syndrome: a gathering challenge in a time of abundance. State of the Art Review. A. Adoles Med 19 (2008) 333-350
101. Harborne L., Fleming R., Lyall H., et al. Metformin or antiandrogen in the treatment of hirsutism in polycystic ovary syndrome. J Clin Endocrinol Metab 88 (2003) 4116-4123
102. Elter K., Imir G., and Durmusoglu F. Clinical, endocrine, and metabolic effects of metformin added to ethinyl estradiol-cyproterone acetate in non-obese women with polycystic ovarian syndrome: a randomized controlled study. Hum Reprod 17 (2002) 1729-1737
103. Farquhar C., Lee O., Toomath R., et al. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne. Cochrane Database Syst Rev 4 (2003) CD000194
104. Kanungo S., and Omar H.A. Hirsutism. In: Hillard P.J.A. (Ed). The 5-Minute Obstetrics and Gynecology Consult (2008), Wolters Kluwer/Lippincott Williams & Wilkins, Philadelphia, PA 24-25
105. Chen E.C., and Brzyski R.G. Exercise and reproductive dysfunction. Fertil Steril 71 (1998) 1-6
106. Marshall L.A. Amenorrhoea. In: Drinkwater B.A. (Ed). Women in Sport (2000), Blackwell Scientific, Oxford 377-390 Ch. 26
107. Harber V.J. Menstrual cycle changes in athletic women: a review. Int Sports Med J 5 (2004) 56-66
108. Greydanus D.E., and Patel D.R. The female athlete: before and beyond puberty. Pediatric Clin North Am 49 (2002) 553-580
109. Yurko-Griffin L., and Harris S.S. Female athletes. In: Sullivan A., and Anderson S. (Eds). American Academy of Orthopedic Surgery and American Academy of Pediatrics (2000) 137-148 Ch. 15
110. Greydanus D.E., and Patel D.R. The female athlete. In: Patel D.R., Greydanus D.E., and Baker R. (Eds). Pediatric Practice: Sports Medicine (2008), McGraw Hill Medical Publishers, New York, NY 222-256 Ch. 10
111. Patel D.R., and Greydanus D.E. The female athlete. In: Omar H., Greydanus D.E., and Tsitsika A. (Eds). Pediatric and Adolescent Sexuality and Gynecology (2009), Novi Science Publishers, Merrick, NY 340-361 Ch. 13
112. Frisch R.E., Wyshak G., and Vincent L. Delayed menarche and amenorrhea in ballet dancers. N Engl J Med 303 (1980) 17
113. Otis C.L., Drinkwater G., Johnson M., et al. ACSM position stand on the female athlete triad. Med Sci Sports Exerc 29 (1997) I-ix
114. Dueck A., Matt K.S., Manore M., et al. Treatment of athletic amenorrhea with a diet and training intervention program. Int J Sport Nutr 6 (1996) 24-40
115. Dusek T. High intensity training and menstrual cycle disorders in athletes. Int Sports Med J 5 (2004) 37-44
116. Manore M.M. Nutritional recommendations and athletic menstrual dysfunction. Int Sports Med J 5 (2004) 45-55
117. Griffin L.Y. The female athlete. In: DeLee J.C., Drez Jr. D., and Miller M.D. (Eds). DeLee and Drez's Orthopaedic Sports Medicine. Principles and Practice (2003), Elsevier/Saunders, Philadelphia, PA 505-520 Ch. 13
118. Gibson J. Osteoporosis. In: Drinkwater B.A. (Ed). Women in Sport (2000), Blackwell Scientific, Oxford 391-406 Ch. 27
119. Committee on Sports Medicine and Fitness, and American Academy of Pediatrics. Amenorrhea in adolescent athletes. Pediatrics 84 (1989) 394-395
120. Greydanus D.E., and Patel D.R. Medical aspects of the female athlete at puberty. Int Sports Med J 5 (2004) 1-25
121. Nattiv A., Arendt E.A., and Hecht S.S. The female athlete. In: Garrett W.E., Kirkendall D.T., and Squire D.L. (Eds). Principles and Practice of Primary Care Sport Medicine (2001), Lippincott Williams and Wilkins, Philadelphia, PA 93-113 ch. 8
122. Committee on Sports Medicine & Nutrition and Fitness, American Academy of Pediatrics. Medical concerns in the female athlete. Pediatrics 106 (2000) 610-613
123. Halpert S., and Warren M.P. Exercise and female adolescents: effects on the reproductive and musculoskeletal systems. Int Sports Med J 5 (2004) 78-88
124. Hillen T.I.J., Grbavac S.L., Johnston P.J., et al. Primary dysmenorrhea in young western Australian women: prevalence, impact, and knowledge of treatment. J Adolesc Health 25 (1999) 40-45
125. Harel Z., and Hillard P.J.A. Dysmenorrhea. In: Hillard P.J.A. (Ed). The 5-Minute Obstetrics and Gynecology Consult (2008), Wolters Kluwer/Lippincott Williams & Wilkins, Philadelphia, PA 30-31
126. Workowski K.A., Dowda D.F., Voight R., et al. Centers for Disease Control and Prevention. 2006 Guidelines for treatment of sexually transmitted diseases. MMWR 55 No. RR-11 (2006) 1-100
127. Johnson J. Level of knowledge among adolescent girls regarding effective treatment for dysmenorrhea. J Adolesc Health Care 9 (1988) 398
128. McDonald M., and Rapkin A. Premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD). In: Hillard P.J.A. (Ed). The 5-Minute Obstetrics and Gynecology Consult (2008), Wolters Kluwer/Lippincott Williams & Wilkins, Philadelphia, PA 160-161
129. Winer S.A. Premenstrual disorders: prevalence, etiology, and impact. J Repro Med 51 suppl 4 (2006) 229-240
130. American Psychiatric Association. DSM-IV: Diagnostic and Statistical Manual of Mental Disorders. 4th ed. (1994), American Psychiatric Association, Washington, DC
131. American Psychiatric Association. DSM-IV-TR: Diagnostic and Statistical Manual of Mental Disorders. 4th ed-text revision (2000), American Psychiatric Association, Washington, DC
132. Endicott J., Amsterdam J., Eriksson E., et al. Is premenstrual dysphoric disorder a distinct clinical entity?. J Womens Health Gend Based Med 8 (1999) 663-679
133. Blake F., Salkovskis P., Gath D., et al. Cognitive therapy for premenstrual syndrome: a controlled trial. J Psychosom Res 45 (1998) 307-318
134. Budeiri D.J., Li W.P., and Dornan J.C. Clinical trials of treatments of premenstrual syndrome: entry criteria and scales for measuring treatment outcomes. Br J Obstet Gynaecol 101 (1994) 689-695
135. Cohen L.S., Miner C., Brown E., et al. Premenstrual daily fluoxetine for prementrual dysphoric disorder: a placebo-controlled clinical trial using computerized diaries. Obstet Gynecol 100 (2002) 435-444
136. Greydanus D.E., Calles J.L., and Patel D.R. Pediatric and Adolescent Psychopharmacology: A Practical Manual for Pediatricians (2008), Cambridge University Press, Cambridge, England 301 pages
137. Stevinson C., and Ernst E. Complementary/alternative therapies for premenstrual syndrome: a systematic review of randomized controlled trials. Am J Obstet Gynecol 185 (2001) 227-235
138. Zurawski J.M. Mittelschmerz. In: Hillard P.J.A. (Ed). The 5-Minute Obstetrics and Gynecology Consult (2008), Wolters Kluwer/Lippincott Williams & Wilkins, Philadelphia, PA 128-129
139. Olive D.L. Endometriosis symposium. Obstet Gynecol Clin North Am 24 (1997) 285
140. Laufer M.R., Sanfilippo J., and Rose G. Adolescent endometriosis: diagnosis and treatment approaches. J Pediatr Adolesc Gynecol 16 (2003) S3
141. Black A.Y., and Jamieson M.A. Adolescent endometriosis. Curr Opin Obstet Gynecol 6 (2002) 467-474
142. Laufer M.R., Goitein B.A., Bush M., et al. Prevalence of endometriosis in adolescent women with chronic pelvic pain not responding to conventional therapy. J Pediatr Adoelsc Gynecol 10 (1997) 199-202
143. Massie J.A.M., Lathi R.B., and Westphal L.M. Endometriosis. In: Hillard P.J.A. (Ed). The 5-minute Obstetrics and Gynecology Consult (2008), Wolters Kluwert/Lippincott Williams & Wilkins, Philadelphia, PA 96-97
144. Sanfilippo J.S. Chronic pelvic pain: medical and surgical approach. In: Sanfilippo J.S., Muran D., Lee P., et al. (Eds). Pediatric and Adolescent Gynecology (1994), WB Saunders, Philadelphia, PA 635
145. Kontoravdis A., Hassan E., Hassiakos D., et al. Laparoscopic evaluation and management of chronic pelvic pain during adolescence. Clin Exp Obstet Gynecol 26 (1999) 76-77
146. Yamamoto K., Mitsuhashi Y., Takaike T., et al. Tubal endometriosis diagnosed within one month after menarche: a case report. Tohoko J Exp Med 181 (1997) 385-387
147. ACOG Practice Bulletin (2004) Chronic pelvic pain, #51, March
148. Latthe P., Mignini L., Gray R., et al. Factors predisposing women to chronic pelvic pain. BMJ 332 (2006) 749-755
149. Beigi R.H. Pelvic inflammatory disease: new diagnostic criteria and treatment. Obstet Gynecol Clin North Am 30 (2003) 777-793
150. Stone S.C. Pelvic pain in children and adolescents. In: Carpenter S.C., and Rock J.A. (Eds). Pediatric and Adolescent Gynecology (1992), Raven Press, New York, NY 267
151. Kennedy S. ESHRE (European Society of Human Reproduction and Embryology) guideline for the diagnosis and treatment of endometriosis. Hum Reprod 20 (2005) 2698-2704
152. Amsterdam L.L. Anastrozole and oral contraceptives: a novel treatment for endometriosis. Fertil Steril 84 (2005) 300
153. Vercellini P., Fedele L., Arcaini L., et al. Laparoscopy in the diagnosis of chronic pelvic pain in adolescent women. J Repo Med 34 (1989) 827
154. Rapkin A.J., and Reading A.E. Chronic pelvic pain. Curr Probl Obstet Gynecol Fertil 14 (1991) 101
155. Goldstein D.P. Acute and chronic pelvic pain. Pediatr Clin North Am 90 (1989) 573